PRDX4 and hepatocellular carcinoma: lncRNA TP53TG1 suppressed the progression of hepatocellular carcinoma through interacting with PRDX4 to promote its ubiquitin-mediated degradation, leading to inactivation of the WNT/β-catenin pathway [40].